Relief-PE
- Product NDC
- 50332-0153
- 11-digit product format
- 503320153
- Labeler code
- 50332
- Product ID
- 50332-0153_129bfe8e-117e-4a42-98eb-e25990b3f2a5
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- ACETAMINOPHEN, PHENYLEPHRINE, CHLORPHENIRAMINE
- Dosage form
- TABLET, COATED
- Route
- ORAL
- Labeler
- HART Health
- Application
- M
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start
- 2012-04-16
- Substance
- ACETAMINOPHEN; PHENYLEPHRINE HYDROCHLORIDE; CHLORPHENIRAMINE MALEATE
- Active strength
- 325; 5; 2 mg/1; mg/1; mg/1
- Pharmacologic classes
- Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-1 Adrenergic Agonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Relief-PE
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| ACETAMINOPHEN | 325 mg/1 |
| PHENYLEPHRINE HYDROCHLORIDE | 5 mg/1 |
| CHLORPHENIRAMINE MALEATE | 2 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 362O9ITL9D | Internal UNII lookup |
| 04JA59TNSJ | Internal UNII lookup |
| V1Q0O9OJ9Z | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 1046781 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 9475fb51-931b-4a89-be6b-62e715d0883e | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| e4e263da-1c53-440f-bb80-b7a575843b5a | Product name | 1 | 20260313 |
| d2168cac-a261-415a-9c78-3522859fa720 | Product name | 3 | 20251124 |
| 05a8cdd1-eeb8-409e-b938-0778225eca7d | Product name | 4 | 20250221 |
| e5b5c132-b15d-435b-9faa-2f74e5cadcf9 | Product name | 8 | 20250220 |
| f489e8f3-5c9e-4818-b539-a73587edcfc7 | Product name | 2 | 20240229 |
| 0f7ae452-206d-4fc4-868d-56fc47074084 | Product name | 1 | 20231011 |
| b5abe2e3-39a1-43eb-9bff-f3c1653fe3df | Product name | 2 | 20190930 |
| d17a97fa-387f-690e-d2be-0083ab044a03 | Product name | 3 | 20170725 |
| 0fdb98e2-b951-a1ce-5715-2b187ba500ef | Product name | 4 | 20170718 |
| e0b6c8be-f2bd-9f86-a9fc-3ed56ffaa814 | Product name | 3 | 20150910 |
| c6fba691-a132-4ede-95c6-f8c6bd696636 | Product name | 1 | 20150902 |
| c0200ab5-4954-454e-9676-30b741b245bd | Product name | 1 | 20150730 |
| 42f3c020-f1b3-89bc-7bdc-e1f10e680485 | Product name | 1 | 20140508 |
| e949165d-714d-e548-2b76-0cb5def16f30 | Product name | 1 | 20140508 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 50332-0153-4 | Relief-PE | 100 in 1 BOX, UNIT-DOSE | TABLET, COATED | 100 | 2 | |
| 50332-0153-7 | Relief-PE | 250 in 1 BOX, UNIT-DOSE | TABLET, COATED | 250 | 2 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 50332-0153 | RELIEF-PE (ACETAMINOPHEN, PHENYLEPHRINE, CHLORPHENIRAMINE) TABLET, COATED [HART HEALTH] | 1 | Current NDC, 2 package rows | 20240217_9475fb51-931b-4a89-be6b-62e715d0883e.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| MAX relief junior | ACETAMINOPHEN | ATLANTIC BIOLOGICALS CORP. | 396903dc-ae2d-4bf4-b1fd-0017b84abef9 | 2024-02-28 | Warnings | M |
| MAX relief junior | ACETAMINOPHEN | ATLANTIC BIOLOGICALS CORP. | 44730cbd-5b98-49bd-b3b8-6fecb0ccd153 | 2024-02-28 | Warnings | M |
| HYDROCORTISONE | HYDROCORTISONE ACETATE | HART Health | 779f945f-ab69-40de-8d86-ab76debc5c7c | 2024-02-16 | Warnings | M |
| First Aid and Burn | BENZALKONIUM CHLORIDE, LIDOCAINE | HART Health | f5746bba-9d7f-4691-b466-14985473bf14 | 2024-02-16 | Warnings | M |
| IBUPROFEN | IBUPROFEN | HART Health | 1c1374e1-890f-48ab-8f93-e84da9d5bf84 | 2024-01-25 | Warnings | M |
| Hand Sanitizer | ANTISEPTIC GEL | HART Health | f07daf29-d0db-4cf8-8baf-d175c2b2ef50 | 2024-01-25 | Warnings | M |
| Hydrogen Peroxide | HYDROGEN PEROXIDE | HART Health | 0346a322-8f6e-405a-8d17-8bc6ce5105a3 | 2024-01-24 | Warnings | M |
| Alcohol | ISOPROPYL ALCOHOL | NorMed | 441b915a-287f-4734-b4d9-730b3d95e04c | 2024-01-24 | Warnings | M |
| Sooth-a-Sting | BENZOCAINE | HART Health | bd7229b6-813a-4149-bfe2-fe682f270ff4 | 2024-01-18 | Warnings | M |
| First Aid | BENZALKONIUM CHLORIDE, BENZOCAINE | HART Health | a6d258ed-6d6d-42f0-9994-6c2c4c3d0f4a | 2024-01-18 | Warnings | M |
| TRIBIOTIC | BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE | HART Health | d8f175f9-f526-4c73-a171-49309ca16cb0 | 2024-01-18 | Warnings, Adverse reactions | M |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 1046781 | acetaminophen 325 MG / chlorpheniramine maleate 2 MG / phenylephrine HCl 5 MG Oral Tablet | PSN | 9475fb51-931b-4a89-be6b-62e715d0883e | 2 |
| 1046781 | acetaminophen 325 MG / chlorpheniramine maleate 2 MG / phenylephrine hydrochloride 5 MG Oral Tablet | SCD | 9475fb51-931b-4a89-be6b-62e715d0883e | 2 |
| 1046781 | APAP 325 MG / chlorpheniramine maleate 2 MG / phenylephrine hydrochloride 5 MG Oral Tablet | SY | 9475fb51-931b-4a89-be6b-62e715d0883e | 2 |
Packages#
| Package NDC | 11-digit format | Description | Marketing start | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|
| 50332-0153-4 | 50332015304 | 100 TABLET, COATED in 1 BOX, UNIT-DOSE (50332-0153-4) | 2012-04-16 | No | No | Current |
| 50332-0153-7 | 50332015307 | 250 TABLET, COATED in 1 BOX, UNIT-DOSE (50332-0153-7) | 2012-04-16 | No | No | Current |